• Something wrong with this record ?

Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C

O. Borgquist, MP. Wise, N. Nielsen, N. Al-Subaie, J. Cranshaw, T. Cronberg, G. Glover, C. Hassager, J. Kjaergaard, M. Kuiper, O. Smid, A. Walden, H. Friberg, . ,

. 2017 ; 45 (8) : 1337-1343.

Language English Country United States

Document type Journal Article, Multicenter Study, Randomized Controlled Trial

OBJECTIVES: Dysglycemia and glycemic variability are associated with poor outcomes in critically ill patients. Targeted temperature management alters blood glucose homeostasis. We investigated the association between blood glucose concentrations and glycemic variability and the neurologic outcomes of patients randomized to targeted temperature management at 33°C or 36°C after cardiac arrest. DESIGN: Post hoc analysis of the multicenter TTM-trial. Primary outcome of this analysis was neurologic outcome after 6 months, referred to as "Cerebral Performance Category." SETTING: Thirty-six sites in Europe and Australia. PATIENTS: All 939 patients with out-of-hospital cardiac arrest of presumed cardiac cause that had been included in the TTM-trial. INTERVENTIONS: Targeted temperature management at 33°C or 36°C. MEASUREMENTS AND MAIN RESULTS: Nonparametric tests as well as multiple logistic regression and mixed effects logistic regression models were used. Median glucose concentrations on hospital admission differed significantly between Cerebral Performance Category outcomes (p < 0.0001). Hyper- and hypoglycemia were associated with poor neurologic outcome (p = 0.001 and p = 0.054). In the multiple logistic regression models, the median glycemic level was an independent predictor of poor Cerebral Performance Category (Cerebral Performance Category, 3-5) with an odds ratio (OR) of 1.13 in the adjusted model (p = 0.008; 95% CI, 1.03-1.24). It was also a predictor in the mixed model, which served as a sensitivity analysis to adjust for the multiple time points. The proportion of hyperglycemia was higher in the 33°C group compared with the 36°C group. CONCLUSION: Higher blood glucose levels at admission and during the first 36 hours, and higher glycemic variability, were associated with poor neurologic outcome and death. More patients in the 33°C treatment arm had hyperglycemia.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030691
003      
CZ-PrNML
005      
20171031105104.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/CCM.0000000000002367 $2 doi
035    __
$a (PubMed)28708678
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Borgquist, Ola $u 1Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.2Department of Clinical Sciences, Lund University, Lund, Sweden.3Adult Critical Care, University Hospital of Wales, Cardiff, United Kingdom.4Department of Anaesthesia and Intensive Care, Intensive Care Unit, Helsingborg Hospital, Sweden.5Cardiothoracic Intensive Care Unit, St. George's Hospital NHS Foundation Trust, London, United Kingdom.6Department of Intensive Care, Royal Bournemouth Hospital, Bournemouth, United Kingdom.7Department of Neurology, Skåne University Hospital, Lund, Sweden.8Department of Critical Care, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.9Department of Cardiology, The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.10Department of Intensive Care, Medical Center Leeuwarden, Leeuwarden, the Netherlands.11Department of Cardiology and Angiology, General University Hospital in Prague, Prague, Czech Republic.12Department of Intensive Care, Royal Berkshire Hospital, Reading, United Kingdom.
245    10
$a Dysglycemia, Glycemic Variability, and Outcome After Cardiac Arrest and Temperature Management at 33°C and 36°C / $c O. Borgquist, MP. Wise, N. Nielsen, N. Al-Subaie, J. Cranshaw, T. Cronberg, G. Glover, C. Hassager, J. Kjaergaard, M. Kuiper, O. Smid, A. Walden, H. Friberg, . ,
520    9_
$a OBJECTIVES: Dysglycemia and glycemic variability are associated with poor outcomes in critically ill patients. Targeted temperature management alters blood glucose homeostasis. We investigated the association between blood glucose concentrations and glycemic variability and the neurologic outcomes of patients randomized to targeted temperature management at 33°C or 36°C after cardiac arrest. DESIGN: Post hoc analysis of the multicenter TTM-trial. Primary outcome of this analysis was neurologic outcome after 6 months, referred to as "Cerebral Performance Category." SETTING: Thirty-six sites in Europe and Australia. PATIENTS: All 939 patients with out-of-hospital cardiac arrest of presumed cardiac cause that had been included in the TTM-trial. INTERVENTIONS: Targeted temperature management at 33°C or 36°C. MEASUREMENTS AND MAIN RESULTS: Nonparametric tests as well as multiple logistic regression and mixed effects logistic regression models were used. Median glucose concentrations on hospital admission differed significantly between Cerebral Performance Category outcomes (p < 0.0001). Hyper- and hypoglycemia were associated with poor neurologic outcome (p = 0.001 and p = 0.054). In the multiple logistic regression models, the median glycemic level was an independent predictor of poor Cerebral Performance Category (Cerebral Performance Category, 3-5) with an odds ratio (OR) of 1.13 in the adjusted model (p = 0.008; 95% CI, 1.03-1.24). It was also a predictor in the mixed model, which served as a sensitivity analysis to adjust for the multiple time points. The proportion of hyperglycemia was higher in the 33°C group compared with the 36°C group. CONCLUSION: Higher blood glucose levels at admission and during the first 36 hours, and higher glycemic variability, were associated with poor neurologic outcome and death. More patients in the 33°C treatment arm had hyperglycemia.
650    _2
$a krevní glukóza $x fyziologie $7 D001786
650    12
$a tělesná teplota $7 D001831
650    _2
$a kardiopulmonální resuscitace $x metody $7 D016887
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a Glasgowská stupnice následků $7 D023261
650    _2
$a lidé $7 D006801
650    _2
$a hyperglykemie $x patofyziologie $7 D006943
650    _2
$a hypoglykemie $x patofyziologie $7 D007003
650    _2
$a terapeutická hypotermie $x metody $7 D007036
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a zástava srdce mimo nemocnici $x mortalita $x patofyziologie $x terapie $7 D058687
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Wise, Matt P
700    1_
$a Nielsen, Niklas
700    1_
$a Al-Subaie, Nawaf $7 gn_A_00004875
700    1_
$a Cranshaw, Julius
700    1_
$a Cronberg, Tobias
700    1_
$a Glover, Guy
700    1_
$a Hassager, Christian
700    1_
$a Kjaergaard, Jesper
700    1_
$a Kuiper, Michael
700    1_
$a Smid, Ondrej
700    1_
$a Walden, Andrew
700    1_
$a Friberg, Hans
700    1_
$a ,
773    0_
$w MED00009514 $t Critical care medicine $x 1530-0293 $g Roč. 45, č. 8 (2017), s. 1337-1343
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28708678 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171031105154 $b ABA008
999    __
$a ok $b bmc $g 1254284 $s 991718
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 45 $c 8 $d 1337-1343 $i 1530-0293 $m Critical care medicine $n Crit Care Med $x MED00009514
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...